Fatty liver, hypertension, and the metabolic syndrome
- PMID: 15194635
- PMCID: PMC1774127
- DOI: 10.1136/gut.2003.037309
Fatty liver, hypertension, and the metabolic syndrome
Abstract
The prevalence of fatty liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.
Comment on
-
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.Gut. 2004 Jul;53(7):1020-3. doi: 10.1136/gut.2003.027086. Gut. 2004. PMID: 15194655 Free PMC article.
References
-
- Bellentani S , Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112–17. - PubMed
-
- Younossi Z , Diehl AM, Ong J. Nonalcoholic fatty lier disease: an agenda for clinical research. Hepatology 2002;35:746–52. - PubMed
-
- Powell EE, Cooksley GE, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients follow for up to 21 years. Hepatology 1990;11:74–80. - PubMed
-
- Teli M , James OF, Burt AD, et al. A natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 1995;22:1714–19. - PubMed
-
- Falck-Ytter Y , Younassi ZM, Marchesini G, et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:71–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical